PT  - JOURNAL ARTICLE
AU  - Stromberg, Zachary R.
AU  - Theiler, James
AU  - Foley, Brian T.
AU  - y Gutiérrez, Adán Myers
AU  - Hollander, Attelia
AU  - Courtney, Samantha J.
AU  - Gans, Jason
AU  - Deshpande, Alina
AU  - Martinez-Finley, Ebany J.
AU  - Mitchell, Jason
AU  - Mukundan, Harshini
AU  - Yusim, Karina
AU  - Kubicek-Sutherland, Jessica Z.
TI  - Fast Evaluation of Viral Emerging Risks (FEVER): A computational tool for biosurveillance, diagnostics, and mutation typing of emerging viral pathogens
AID  - 10.1101/2021.05.25.21257811
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.25.21257811
4099  - http://medrxiv.org/content/early/2021/05/27/2021.05.25.21257811.short
4100  - http://medrxiv.org/content/early/2021/05/27/2021.05.25.21257811.full
AB  - Viral pathogen can rapidly evolve, adapt to novel hosts and evade human immunity. The early detection of emerging viral pathogens through biosurveillance coupled with rapid and accurate diagnostics are required to mitigate global pandemics. However, RNA viruses can mutate rapidly, hampering biosurveillance and diagnostic efforts. Here, we present a novel computational approach called FEVER (Fast Evaluation of Viral Emerging Risks) to design assays that simultaneously accomplish: 1) broad-coverage biosurveillance of an entire class of viruses, 2) accurate diagnosis of an outbreak strain, and 3) mutation typing to detect variants of public health importance. We demonstrate the application of FEVER to generate assays to simultaneously 1) detect sarbecoviruses for biosurveillance; 2) diagnose infections specifically caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); and 3) perform rapid mutation typing of the D614G SARS-CoV-2 spike variant associated with increased pathogen transmissibility. These FEVER assays had a high in silico recall (predicted positive) up to 99.7% of 525,708 SARS-CoV-2 sequences analyzed and displayed sensitivities and specificities as high as 92.4% and 100% respectively when validated in 100 clinical samples. The D614G SARS-CoV-2 spike mutation PCR test was able to identify the single nucleotide identity at position 23,403 in the viral genome of 96.6% SARS-CoV-2 positive samples without the need for sequencing. This study demonstrates the utility of FEVER to design assays for biosurveillance, diagnostics, and mutation typing to rapidly detect, track, and mitigate future outbreaks and pandemics caused by emerging viruses.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by Los Alamos National Laboratory Exploratory Research and Development grant number 20190392ER (to J.K.S and K.Y.) and Los Alamos National Laboratory Technology Evaluation and Demonstration Funds.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was designed in alignment with DOE, NIH, and universal HIPAA guidelines. The protocol was reviewed and approved by the Institutional Review Board of the Los Alamos National Laboratory (LANL#000473), per DOE guidelines and policies, and by the Presbyterian Institutional Review Board (PHS IRB#1608836).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code written in support of this publication is publicly available at https://github.com/jt-lanl/fever-probes. https://github.com/jt-lanl/fever-probes